Attached files

file filename
XML - IDEA: XBRL DOCUMENT - PROTALEX INCR25.htm
EX-4.1 - EXHIBIT 4.1 - PROTALEX INCv330852_ex4-1.htm
EX-4.2 - EXHIBIT 4.2 - PROTALEX INCv330852_ex4-2.htm
EX-10.2 - EXHIBIT 10.2 - PROTALEX INCv330852_ex10-2.htm
EX-32.2 - EXHIBIT 32.2 - PROTALEX INCv330852_ex32-2.htm
EX-32.1 - EXHIBIT 32.1 - PROTALEX INCv330852_ex32-1.htm
EX-10.1 - EXHIBIT 10.1 - PROTALEX INCv330852_ex10-1.htm
EX-31.1 - EXHIBIT 31.1 - PROTALEX INCv330852_ex31-1.htm
EX-31.2 - EXHIBIT 31.2 - PROTALEX INCv330852_ex31-2.htm
EXCEL - IDEA: XBRL DOCUMENT - PROTALEX INCFinancial_Report.xls
10-Q - FORM 10-Q - PROTALEX INCv330852_10q.htm
XML - IDEA: XBRL DOCUMENT - PROTALEX INCR4.htm
XML - IDEA: XBRL DOCUMENT - PROTALEX INCR6.htm
XML - IDEA: XBRL DOCUMENT - PROTALEX INCR8.htm
XML - IDEA: XBRL DOCUMENT - PROTALEX INCR3.htm
XML - IDEA: XBRL DOCUMENT - PROTALEX INCR2.htm
XML - IDEA: XBRL DOCUMENT - PROTALEX INCR9.htm
XML - IDEA: XBRL DOCUMENT - PROTALEX INCR5.htm
XML - IDEA: XBRL DOCUMENT - PROTALEX INCR1.htm
XML - IDEA: XBRL DOCUMENT - PROTALEX INCR27.htm
XML - IDEA: XBRL DOCUMENT - PROTALEX INCR26.htm
XML - IDEA: XBRL DOCUMENT - PROTALEX INCR22.htm
XML - IDEA: XBRL DOCUMENT - PROTALEX INCR10.htm
XML - IDEA: XBRL DOCUMENT - PROTALEX INCR13.htm
XML - IDEA: XBRL DOCUMENT - PROTALEX INCR24.htm
XML - IDEA: XBRL DOCUMENT - PROTALEX INCR18.htm
XML - IDEA: XBRL DOCUMENT - PROTALEX INCR23.htm
XML - IDEA: XBRL DOCUMENT - PROTALEX INCR12.htm
XML - IDEA: XBRL DOCUMENT - PROTALEX INCR15.htm
XML - IDEA: XBRL DOCUMENT - PROTALEX INCR20.htm
XML - IDEA: XBRL DOCUMENT - PROTALEX INCR14.htm
XML - IDEA: XBRL DOCUMENT - PROTALEX INCR21.htm
XML - IDEA: XBRL DOCUMENT - PROTALEX INCR19.htm
XML - IDEA: XBRL DOCUMENT - PROTALEX INCR17.htm
XML - IDEA: XBRL DOCUMENT - PROTALEX INCR11.htm
XML - IDEA: XBRL DOCUMENT - PROTALEX INCR16.htm
v2.4.0.6
STATEMENTS OF CASH FLOWS (USD $)
6 Months Ended 158 Months Ended
Nov. 30, 2012
Nov. 30, 2011
Nov. 30, 2012
CASH FLOWS FROM OPERATING ACTIVITIES:      
Net loss $ (2,784,998) $ (2,133,847) $ (58,239,817)
Adjustments to reconcile net loss to net cash and cash equivalents used in operating activities      
(Gain) on disposal of equipment, net 0 0 (81,544)
Depreciation and amortization 468,460 510 2,438,580
Equity based expense 342,312 979,363 8,029,308
(Increase)/decrease in:      
Prepaid expenses and deposits (42,894) (40,932) (93,563)
Increase/(decrease) in:      
Accounts payable and accrued expenses 59,136 195,318 828,813
Net cash and cash equivalents used in operating activities (1,957,984) (999,588) (47,118,223)
CASH FLOWS FROM INVESTING ACTIVITIES:      
Acquisition of intellectual technology license - fee portion 0 0 (20,000)
Refund of security deposits 0 0 7,990
Acquisition of equipment 0 0 (905,936)
Excess of amounts paid for public shell over assets acquired to be accounted for as a recapitalization 0 0 (250,000)
Proceeds from disposal of equipment 0 0 229,135
Net cash and cash equivalents used in investing activities 0 0 (938,811)
CASH FLOWS FROM FINANCING ACTIVITIES:      
Proceeds from stock issuance, including options and warrants exercised 0 0 42,658,458
Principal payment on equipment notes payable and capital leases 0 0 (295,411)
Contribution by stockholders 0 0 183,569
Principal payment on note payable to individuals 0 0 (225,717)
Issuance of note payable to individuals 1,800,000 0 6,168,546
Acquisition of common stock 0 0 (400,000)
Net cash and cash equivalents provided by financing activities 1,800,000 0 48,089,445
NET (DECREASE) INCREASE IN CASH AND CASH EQUIVALENTS (157,984) (999,588) 32,411
Cash and cash equivalents, beginning of period 190,395 1,542,025 0
Cash and cash equivalents, ending of period 32,411 542,437 32,411
SUPPLEMENTAL SCHEDULE OF CASH FLOW INFORMATION:      
Interest paid 0 0 66,770
Taxes paid 0 0 100
NON-CASH FINANCING ACTIVITIES:      
Conversion of debt for equity $ 0 $ 0 $ 1,037,500